BUPLEX JUNIOR 100 MG/5ml Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

buplex junior 100 mg/5ml oral suspension

actavis group ptc ehf - ibuprofen - oral suspension - 100 mg/5ml - propionic acid derivatives - anti-inflammatory and antirheumatic products, non-steroids; propionic acid derivatives - it is indicated in children 3 months to 12 years (> 5 kg) for: the reduction of fever, including post immunisation pyrexia; the relief of the symptoms of colds and influenza; the relief of mild to moderate pain, such as a sore throat, teething pain, toothache, earache, headache, minor aches and sprains

CHILDREN'S MOTRIN COLD SUSPENSION Canada - English - Health Canada

children's motrin cold suspension

mcneil consumer healthcare division of johnson & johnson inc - ibuprofen; pseudoephedrine hydrochloride - suspension - 100mg; 15mg - ibuprofen 100mg; pseudoephedrine hydrochloride 15mg - other nonsteroidal antiimflammatory agents

IBUPROFEN- ibuprofen suspension United States - English - NLM (National Library of Medicine)

ibuprofen- ibuprofen suspension

lake erie medical dba quality care products llc - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 100 mg in 5 ml - carefully consider the potential benefits and risks of ibuprofen oral suspension and other treatment options before deciding to use ibuprofen oral suspension. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). in pediatric patients , ibuprofen oral suspension is indicated: in adults , ibuprofen oral suspension is indicated: since there have been no controlled trials to demonstrate whether there is any beneficial effect or harmful interaction with the use of ibuprofen in conjunction with aspirin, the combination cannot be recommended (see precautions - drug interactions ). ibuprofen oral suspension is contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen oral suspension should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings